Indeed, Wnt/beta-catenin target genes involved in bone metabolism, such as BMP2, BMP4, PTGS2 and MMP16, showed high expression levels in osteoblastoma [19-25]. This evidence concerns the gene BMP2 and Osteoblastoma.